https://ml133inhibitor.com/onl....ine-sales-compliance
A retrospective study examined the clinical presentation and prognosis of 29 high-risk neuroblastoma patients treated with high-dose chemotherapy combined with autologous stem cell transplantation (ASCT) at Shanghai Children's Hospital between 2013 and 2021. Among the 29 pediatric patients treated with a combination of high-dose chemotherapy and ASCT, 18 were boys (62 percent) and 11 were girls (38 percent), and the median age at symptom onset was 36 months (with a